1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Pandemic Influenza Global Clinical Trials Review, H1, 2016

Pandemic Influenza Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, “Pandemic Influenza Global Clinical Trials Review, H1, 2016" provides an overview of Pandemic Influenza clinical trials scenario. This report provides top line data relating to the clinical trials on Pandemic Influenza. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Pandemic Influenza Global Clinical Trials Review, H1, 2016
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Pandemic Influenza to Infectious Disease Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Pandemic Influenza to Infectious Disease Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Pandemic Influenza Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profile Snapshots 28
Appendix 89
Abbreviations 89
Definitions 89
Research Methodology 90
Secondary Research 90
About GlobalData 91
Contact Us 91
Disclaimer 91
Source 92

List of Tables
Pandemic Influenza Therapeutics, Global, Clinical Trials by Region, 2016* 6
Pandemic Influenza Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Pandemic Influenza Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Pandemic Influenza Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Pandemic Influenza Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Pandemic Influenza Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Pandemic Influenza Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 12
Proportion of Pandemic Influenza to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 13
Pandemic Influenza Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Pandemic Influenza Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Pandemic Influenza to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 16
Pandemic Influenza Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
Pandemic Influenza Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18
Pandemic Influenza Therapeutics, Global, Clinical Trials by Phase, 2016* 19
Pandemic Influenza Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 20
Pandemic Influenza Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
Pandemic Influenza Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
Pandemic Influenza Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
Pandemic Influenza Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 24
Pandemic Influenza Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
Pandemic Influenza Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26
Pandemic Influenza Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27

List of Figures
Pandemic Influenza Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Pandemic Influenza Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Pandemic Influenza Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Pandemic Influenza Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Pandemic Influenza Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Pandemic Influenza Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Pandemic Influenza Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 12
Proportion of Pandemic Influenza to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 13
Pandemic Influenza Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Pandemic Influenza Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Pandemic Influenza to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 16
Pandemic Influenza Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
Pandemic Influenza Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18
Pandemic Influenza Therapeutics, Global, Clinical Trials by Phase (%), 2016* 19
Pandemic Influenza Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 20
Pandemic Influenza Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
Pandemic Influenza Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
Pandemic Influenza Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
Pandemic Influenza Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 24
Pandemic Influenza Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
Pandemic Influenza Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26
Pandemic Influenza Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27
GlobalData Methodology 90

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Influenza Diagnostics Market By Test Type, By End Use and Segment Forecasts to 2024

Influenza Diagnostics Market By Test Type, By End Use and Segment Forecasts to 2024

  • $ 4950
  • Industry report
  • September 2016
  • by Grand View Research

The influenza diagnostics market is expected to reach USD 3.3 billion by 2024, according to a new report by Grand View Research, Inc. Influenza, or "the flu," is an infectious disease and affects the uppe ...

H1N1 (Swine Influenza)- Market Insights, Epidemiology and Market Forecast-2023

H1N1 (Swine Influenza)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s H1N1 (Swine Influenza) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...

Influenza Diagnostics Market By Test Type (Rapid Influenza Diagnostic Test [RIDT], Reverse Transcription Polymerase Chain Reaction[RT-PCR], Cell Culture, Others - Immunofluorescence, Serology), By End Use, And Segment Forecasts To 2024

Influenza Diagnostics Market By Test Type (Rapid Influenza Diagnostic Test [RIDT], Reverse Transcription Polymerase Chain Reaction[RT-PCR], Cell Culture, Others - Immunofluorescence, Serology), By End Use, And Segment Forecasts To 2024

  • $ 4950
  • Industry report
  • September 2016
  • by Grand View Research

The influenza diagnostics market is expected to reach USD 3.3 billion by 2024, according to a new report by Grand View Research, Inc. Influenza, or "the flu," is an infectious disease and affects the uppe ...


Download Unlimited Documents from Trusted Public Sources

Infectious Disease Statistics in the US

  • December 2016
    32 pages
  • Infectious Dise...  

    Asthma  

  • United States  

View report >

The future of the Vaccine Industry in the UK

  • December 2016
    2 pages
  • Vaccine  

    Infectious Dise...  

  • United Kingdom  

View report >

Infectious Disease Statistics in Brazil

  • December 2016
    9 pages
  • Infectious Dise...  

    Hospital  

  • Brazil  

View report >

Related Market Segments :

Influenza
Clinical Trial
Vaccine

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.